# Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

> **NCT07458659** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Chulalongkorn University** · enrollment: 3 (estimated)

## Conditions studied

- Relapsed/Refractory Multiple Myeloma (MM)

## Interventions

- **BIOLOGICAL:** Chimeric Antigen Receptor T Cells (CAR-T)

## Key facts

- **NCT ID:** NCT07458659
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-06-01
- **Final completion:** 2029-06-01
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07458659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07458659, "Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07458659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*